Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
Status:
Withdrawn
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is a randomised, comparative, multicentre study to determine if the early recurrence
rate of intermediate-risk bladder cancer is similar in subjects treated with multiple
instillations of mitomycin C after resection conducted under white light cystoscopy (group A)
and subjects treated with 1 instillation of mitomycin C after resection conducted under white
light and blue light cystoscopy (group B).